Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Pathol Res Pract ; 218: 153317, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33360970

ABSTRACT

Monoclonal gammopathy of undetermined significance (MGUS) is a pre-malignant abnormality of plasma cells, with increased serum levels of immunoglobulins. Patients with MGUS may evolve to multiple myeloma through a multistep process including deregulated gene expression. microRNAs are small non-coding RNA molecules involved in post-transcriptional regulation of crucial biological processes, such as morphogenesis, cell differentiation, apoptosis, and cancer. This study aimed to evaluate microRNA expression on peripheral lymph-monocytes from MGUS subjects compared with healthy controls using qPCR arrays. Blood samples were collected by venipuncture from fifteen, newly diagnosed MGUS patients and fifteen healthy subjects. A further group (validation group) of six newly diagnosed MGUS patients and five healthy control were enrolled for the validation of miRNAs and their mRNAs target. The study was conducted performing miProfile miRNA qPCR arrays, followed by validation of miRNAs and related mRNA targets through RT-qPCR. The functional interaction between microRNAs and target gene were obtained by Ingenuity Pathways Analysis (IPA). IPA network analysis identified only molecules and relationships experimentally observed in peripheral lymphomonocytes. The following miRNAs :133a-3p, 16-5p, 291-3p, 23a-3p, 205-5p, 17-5p, 7a-5p, 221-3p, 30c-5p, 126a-3p,155-5p, let-7a-5p and 26a-5p, involved in the regulation of genes with a role in lymphocyte homeostasis, cell proliferation, apoptosis, and multiple myeloma (MM) progression, were differently expressed in MGUS with respect to healthy subjects. This miRNA signature and its relative targets could be considered for the formulation of new therapeutic strategies in the prophylaxis or treatment of monoclonal gammopathies.


Subject(s)
Gene Expression Profiling , Lymphocytes/immunology , MicroRNAs/genetics , Monoclonal Gammopathy of Undetermined Significance/genetics , Monocytes/immunology , Polymerase Chain Reaction , Transcriptome , Aged , Case-Control Studies , Female , Gene Regulatory Networks , Humans , Male , Middle Aged , Monoclonal Gammopathy of Undetermined Significance/diagnosis , Monoclonal Gammopathy of Undetermined Significance/immunology , Predictive Value of Tests
2.
Biomed Res Int ; 2020: 9879876, 2020.
Article in English | MEDLINE | ID: mdl-32714991

ABSTRACT

Bisphosphonates (BPs) are inhibitors of osteoclast-mediated bone resorption used for the treatment of multiple myeloma (MM) patients with osteolytic lesions. Bisphosphonate-induced osteonecrosis of the jaw (BONJ) is an infrequent drug-caused adverse event of these agents. Long noncoding RNAs (lncRNAs) are a set of more than 200 base pairs, noncoding RNA molecules, which are critical posttranscriptional regulators of gene expression. Our study was aimed at evaluating 17 lncRNAs, whose targets were previously validated as key elements in MM, bone metabolism, and angiogenesis in MM subjects without BONJ (MM group), in MM subjects with BONJ (BONJ group), and a group of healthy controls (CTRL group). Our results demonstrated a different lncRNA profile in BONJ patients compared to MM patients and controls. Two lncRNAs (DANCR and MALAT1) were both downregulated compared to controls and MM, twelve (HOTAIR, MEG3, TP73-AS1, HOTTIP, HIF1A-AS2, MANTIS, CTD-2201E18, CTD1-2003C8, R-471B22, RP1-43E13, RP11-553L6.5, and RP1-286D6) were overexpressed in MM with BONJ, and one (H19) was upregulated compared with only MM. Two lncRNAs (JHDMD1 and MTMR9LP) had higher expression, but these differences were not statistically significant. The examined lncRNAs target several genes and metabolic pathways. An altered lncRNA signature could contribute to the onset of BONJ or have a protective action. Targeting these lncRNAs could offer a possibility for the prevention or therapy of BONJ.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/complications , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Multiple Myeloma/complications , Multiple Myeloma/genetics , RNA, Long Noncoding/genetics , Case-Control Studies , Female , Humans , Male , Middle Aged , RNA, Long Noncoding/metabolism
3.
Int J Mol Sci ; 20(20)2019 Oct 15.
Article in English | MEDLINE | ID: mdl-31619003

ABSTRACT

BACKGROUND: Obesity is a pathological condition that has reached epidemic proportions; hence, it is necessary to find novel strategies aimed at fighting this disease. The present study was designed to evaluate the effect of a flavonoid-rich extract of orange (Citrus sinensis) juice (OJe) in diet-induced obese zebrafish. METHODS: Adult zebrafish were divided into four diet groups: (i) normally fed (NF); (ii) overfed (OF); (iii) NF supplemented with OJe (5 mL/L in fish water; NF + OJe); and (iv) OF supplemented with OJe (OF + OJe). Each week, body weight (BW) and body mass index (BMI) were measured, and, at the end of the fifth week, euthanized zebrafish were processed for both microscopic evaluations and qPCR analyses. RESULTS: In OF zebrafish, OJe significantly decreased both BW and BMI values and lowered the visceral adipose tissue, while it had little effect in the NF group. Moreover, it significantly reduced adipocyte cell size in both NF and OF groups in both visceral and subcutaneous adipose tissues, as well as their number in OF fish. Finally, OJe modulated some obesity-related genes, such as leptin A, ghrelin, orexin, pro-opiomelanocortin (POMC), and neuropeptide Y (NPY), in both gut and brain. CONCLUSION: This study adds new insights into the anti-obesity properties of orange juice and its flavonoids, suggesting their role as weight management agents through a lipolytic action linked to a restoration of metabolism-regulating gene expression.


Subject(s)
Citrus sinensis/chemistry , Diet/adverse effects , Flavonoids/pharmacology , Fruit and Vegetable Juices , Obesity/drug therapy , Obesity/etiology , Plant Extracts/pharmacology , Adipocytes/metabolism , Adipose Tissue/metabolism , Animals , Biomarkers , Body Weight , Flavonoids/chemistry , Gene Expression Profiling , Immunohistochemistry , Lipolysis , Obesity/pathology , Plant Extracts/chemistry , Zebrafish
4.
Fish Physiol Biochem ; 45(3): 943-954, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30627834

ABSTRACT

Teleost haemoglobins vary in polymorphisms and primary structure, although display similar functional properties. Key amino acids for Root effect (a reduction in oxygen-carrying capacity and loss of cooperativity with declining pH) are conserved throughout fish evolution. For the first time, we cloned and characterised Sparus aurata L. embryonic globin chains (eα1, eα2, eß). We also studied haemoglobins (eHbI, eHbII) behaviour in normal and low-oxygen conditions. Several amino acids in fry globins are different in chemical type (e.g. polar → non-polar and vice versa), compared to adult globins. His55α1, crucial for Root effect, is substituted by Ala in fry, presumably enhancing oxygen capture, transport and reducing the dependence of Root effect from pH. Phylogenetic trees demonstrate that eα1 globin diversified more recently than eα2; moreover, eα1, eα2 and eß globins evolved earlier than adult α and ß globins. In low-oxygen conditions, fry haemoglobins display the same behaviour of the adult haemoglobins (probably, embryonic and adult-type I Hbs display a higher oxygen affinity than type II Hbs, operating through a rapid cycle of heme-Fe auto-oxidation/reduction). Therefore, based on our results and on the comparison with adult haemoglobins, we hypothesise that embryonic haemoglobins have evolved to better adapt fry to variable habitats. We studied Sparus aurata for its economical relevance in Mediterranean aquaculture. The information we provide can help understand Sparus aurata behaviour in the wild and in rearing conditions. Further studies with functional assays will deepen the knowledge on the molecular mechanisms of fry haemoglobin physiology.


Subject(s)
Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Developmental/physiology , Hemoglobins/metabolism , Oxygen/metabolism , Sea Bream/embryology , Amino Acid Sequence , Animals , Biological Evolution , Fish Proteins , Hemoglobins/genetics , Hypoxia , Sea Bream/metabolism
5.
Ann Hematol ; 97(7): 1259-1269, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29546453

ABSTRACT

Bisphosphonates are formidable inhibitors of osteoclast-mediated bone resorption employed for therapy of multiple myeloma (MM) subjects with osteolytic lesions. Osteonecrosis of the jaw (ONJ) is an uncommon drug-induced adverse event of these agents. MicroRNAs (miRNAs) are a group of small, noncoding RNAs nucleotides, which are essential post-transcriptional controllers of gene expression. They have a central role in the normal bone development. The goal of our study was to investigate 18 miRNAs, whose targets were previously validated and described in MM subjects without ONJ, in peripheral lymphocytes of MM subjects with bisphosphonate-induced ONJ. Utilizing reverse transcription quantitative polymerase chain reaction, we evaluated miRNAs in five healthy subjects and in five MM patients with ONJ. Our experimental data revealed that a diverse miRNA signature for ONJ subjects emerged with respect to control subjects. Using the filter for in silico analysis, among the 18 miRNAs, we recognized 14 dysregulated miRNAs. All these miRNAs were significantly over-expressed in patients vs controls (MIR-16-1, MIR-21, MIR-23A, MIR-28, MIR-101-1, MIR-124-1, MIR-129, MIR-139, MIR-145, MIR-149, MIR-202, MIR-221, MIR-424, MIR-520). Among them, six were strongly upregulated (fourfold upregulated and more). These miRNAs target numerous pathways and genes implicated in calcium ion binding, bone resorption, mineralization of bone matrix, and differentiation and maintenance of bone tissue. A modified microRNA expression profile after zoledronate therapy could participate to the onset of ONJ. Targeting these miRNAs could provide a new opportunity for the prevention or treatment of ONJ.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/genetics , Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Gene Expression Regulation, Neoplastic , Imidazoles/adverse effects , Lymphocytes/metabolism , MicroRNAs/biosynthesis , Monocytes/metabolism , Multiple Myeloma/genetics , RNA, Neoplasm/biosynthesis , Aged , Bisphosphonate-Associated Osteonecrosis of the Jaw/blood , Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Gene Ontology , Humans , Male , MicroRNAs/blood , MicroRNAs/genetics , Middle Aged , Multiple Myeloma/blood , Multiple Myeloma/complications , Osteoclasts/metabolism , Osteolysis/blood , Osteolysis/drug therapy , Osteolysis/etiology , RNA, Neoplasm/blood , RNA, Neoplasm/genetics , Reverse Transcriptase Polymerase Chain Reaction , Zoledronic Acid
6.
Ann Anat ; 204: 36-44, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26617157

ABSTRACT

Obesity is a multifactorial disease generated by an alteration in balance between energy intake and expenditure, also dependent on genetic and non-genetic factors. Moreover, various nuclei of the hypothalamus receive and process peripheral stimuli from the gastrointestinal tract, controlling food intake and therefore energy balance. Among anorexigenic molecules, brain-derived neurotrophic factor (BDNF) acts through the tyrosine-kinase receptor TrkB. Numerous data demonstrate that the BDNF/TrkB system has a fundamental role in the control of food intake and body weight. Quantitative PCR and immunohistochemistry for both BDNF and TrkB were used to determine changes in levels in the brain and gastro-intestinal tract of an experimental zebrafish model of diet-induced obesity. Overfed animals showed increased weight and body mass index as well as accumulation of adipose tissue in the visceral, subcutaneous and hepatic areas. These changes were concomitant with decreased levels of BDNF mRNA in the gastro-intestinal tract and increased expression of TrkB mRNA in the brain. Overfeeding did not change the density of cells displaying immunoreactivity for BDNF or TrkB in the brain although both were significantly diminished in the gastro-intestinal tract. These results suggest an involvement of the BDNF/TrkB system in the regulation of food intake and energy balance in zebrafish, as in mammals.


Subject(s)
Adipose Tissue/pathology , Brain Chemistry/genetics , Brain-Derived Neurotrophic Factor/genetics , Diet , Gastrointestinal Tract/metabolism , Obesity/genetics , Obesity/metabolism , Receptor, trkB/genetics , Animals , Body Mass Index , Body Weight , Brain-Derived Neurotrophic Factor/biosynthesis , Eating , Energy Metabolism/genetics , Liver/metabolism , Male , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Receptor, trkB/biosynthesis , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...